VentiRx Pharmaceuticals' Acquisition

VentiRx Pharmaceuticals was acquired by Celgene on February 14, 2017.

VentiRx Pharmaceuticals is a clinical stage biopharmaceutical company committed to the development and commercialization of novel Toll-like receptor 8 (TLR8) immunotherapies for the treatment of cance…

Articles about VentiRx Pharmaceuticals' Acquisition: